Showing results (1481-1490 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|February 11, 2019
Disease modifying therapies continue to drive up health care cost among individuals with multiple sclerosisYoungran Kim, Trudy Millard Krause, Philip Blum, et al.
Multiple Sclerosis and Related Disorders|November 23, 2019
Who is not coming to clinic? A predictive model of excessive missed appointments in persons with multiple sclerosisElizabeth S Gromisch, Aaron P Turner, Steven L Leipertz, et al.
Multiple Sclerosis and Related Disorders|November 12, 2019
Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibodyMitsugu Yanagidaira, Takaaki Hattori, Hirofumi Emoto, et al.
Multiple Sclerosis and Related Disorders|December 24, 2017
The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosisRuth Ann Marrie, Lixia Zhang, Lisa M Lix, et al.
Multiple Sclerosis and Related Disorders|December 26, 2017
Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapyElijah Edward Rhone, Peter Siu Pan Cho, Surinder S Birring, et al.
Multiple Sclerosis and Related Disorders|December 2, 2017
Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving FingolimodNavid Manouchehri, Omid Mirmosayyeb, Shervin Badihian, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Short term outcome of ADEM: Results from a retrospective cohort study from South IndiaMary Iype, P A Mohammed Kunju, Geetha Saradakutty, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapseJahir Miranda Acuña, Milagros Hidalgo de la Cruz, Alberto Lozano Ros, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Examining the contributions of environmental quality to pediatric multiple sclerosisAmy M Lavery, Amy T Waldman, T Charles Casper, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatmentDavid Baker, Gavin Giovannoni, Klaus Schmierer
Pageof 515